Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 422-600-5 | CAS number: 73936-91-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://www.echa.europa.eu/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Endpoint summary
Administrative data
Description of key information
The test item did not induce acute toxicity after oral and dermal application at 2000 mg/kg.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 29-Oct-1996 to 19-Nov-1996
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP guideline study (OECD test guideline 401)
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Version / remarks:
- adopted on 24-Feb-1987
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.1 (Acute Toxicity (Oral))
- Deviations:
- no
- GLP compliance:
- yes
- Test type:
- standard acute method
- Limit test:
- yes
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: BRL Ltd, Wölferstrasse 4, 4414 Füllinsdorf, Switzerland
- Age at study initiation: 8 weeks old (males), 10 weeks old (females)
- Weight at study initiation: 192.9-212.3 g (males), 179.2-188.0 g (females)
- Fasting period before study: overnight fasting prior to the single test item application
- Housing: groups of 5 rats/sex in Makrolon type-4 cages
- Diet: pelleted standard rat maintenance diet (Kliba 343, Kliba Mühlen AG, 4303 Kaiseraugst, Switzerland), ad libitum (with exception of an overnight fasting period prior to dosing; food was provided again 3 hours after dosing)
- Water: tap water, ad libitum
- Acclimation period: 1 week
ENVIRONMENTAL CONDITIONS
- Temperature: 22 ± 3 °C
- Humidity: 40-70 %
- Air changes: 10-15 changes/hour
- Photoperiod: 12 hours dark / 12 hours light
IN-LIFE DATES: 29-Oct-1996 to 19-Nov-1996 - Route of administration:
- oral: gavage
- Vehicle:
- other: bidistilled water with a drop of Tween 80
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: 200 mg/mL
- Amount of vehicle: 10 mL/kg bw
- Justification for choice of vehicle: standard vehicle for studies of this type
DOSAGE PREPARATION:
The test article was placed into a glass beaker on a tared Mettler PM 460 balance and the vehicle (bi-distilled water with a drop of TWEEN 80) was added. A weight by volume dilution was prepared using a glass rod and a magnetic stirrer as homogenizers. Homogeneity of the test article in the vehicle was maintained during treatment using the same magnetic stirrer (Janke & Kunkel, 0-79219 Staufen). The preparation was made shortly before dosing. - Doses:
- 2000 mg/kg bw
- No. of animals per sex per dose:
- 5
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations: four times during day 1 and once daily thereafter
- Frequency of weighing: on days 1 (prior to administration), 8 and 15
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs - Statistics:
- The LOGIT-model could not be used as no deaths occurred.
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- No deaths occurred during the study.
- Clinical signs:
- other: No clinical signs of toxicity were observed during the study period.
- Gross pathology:
- No macroscopic findings were observed at necropsy.
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- The mean lethal dose of the test item after single oral administration to rats of both sexes, observed over a period of 14 days was found to be greater than 2000 mg/kg.
- Executive summary:
In a GLP-compliant acute oral toxicity study according to OECD guideline 401, a group of five male and five female HanIbm:WIST (SPF) rats was treated with test material at 2000 mg/kg by oral gavage. The test article was suspended in vehicle (bi-distilled water and a drop of TWEEN 80) at a concentration of 0.2 g/ml and administered at a volume of 10 ml/kg. Four times during day 1 and once daily during days 2-15 the animals were examined for clinical signs. Mortality/viability were recorded together with clinical signs at the same time intervals. Body weights were recorded on day 1 before administration and on days 8 and 15. All animals were necropsied and examined macroscopically. No deaths occurred during the study. No clinical signs of toxicity were observed during the observation period. The body weight of the animals was within the range of physiological variability known for rats of this strain and age. No macroscopic findings were observed at necropsy. In conclusion, the mean lethal dose (LD50) of the test item after single oral administration to rats of both sexes, observed over a period of 14 days, was found to exceed 2000 mg/kg.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- discriminating dose
- Value:
- 2 000 mg/kg bw
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 29-Oct-1996 to 19-Nov-1996
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP guideline study (OECD test guideline 402)
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 402 (Acute Dermal Toxicity)
- Version / remarks:
- adopted on 24-Feb-1987
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.3 (Acute Toxicity (Dermal))
- Deviations:
- no
- GLP compliance:
- yes
- Test type:
- standard acute method
- Limit test:
- yes
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: BRL Ltd, Wölferstrasse 4, 4414 Füllinsdorf, Switzerland
- Age at study initiation: 8 weeks old (males), 11 weeks old (females)
- Weight at study initiation: 231.1-253.2 g (males), 202.3-224.0 g (females)
- Housing: groups of 5 rats/sex in Makrolon type-4 cages
- Diet: pelleted standard rat maintenance diet (Kliba 343, Kliba Mühlen AG, 4303 Kaiseraugst, Switzerland), ad libitum
- Water: tap water, ad libitum
- Acclimation period: 1 week
ENVIRONMENTAL CONDITIONS
- Temperature: 22 ± 3 °C
- Humidity: 40-70 %
- Air changes: 10-15 changes/hour
- Photoperiod: 12 hours dark / 12 hours light
IN-LIFE DATES: 29-Oct-1996 to 19-Nov-1996 - Type of coverage:
- semiocclusive
- Vehicle:
- other: bidistilled water with a drop of Tween 80
- Details on dermal exposure:
- TEST SITE
- Area of exposure: 10 % of total body surface area
- Type of wrap: wrap type not indicated, wrap was fixed with an elastic adhesive bandage
REMOVAL OF TEST SUBSTANCE
- Washing: with lukewarm water
- Time after start of exposure: 24 hours
TEST MATERIAL
- Amount applied: 4 mL/kg bw
- Concentration: 500 mg/mL
- Constant volume or concentration used: yes (per kg bw)
VEHICLE
- Amount applied: dose volume of 4 mL/kg bw - Duration of exposure:
- 24 hours
- Doses:
- 2000 mg/kg bw
- No. of animals per sex per dose:
- 5
- Control animals:
- not required
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations: mortality and clinical signs were assessed four times on day 1 and once daily thereafter
- Frequency of weighing: on days 1 (pre-administration), 8 and 15.
- Necropsy of survivors performed: yes, including macroscopical examination - Statistics:
- The LOGIT-Model could not be used as no deaths occurred.
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- No deaths occurred during the study.
- Clinical signs:
- other: Neither clinical signs of systemic toxicity nor local effects of the test item on the skin at the application site were observed during the observation period.
- Gross pathology:
- No macroscopic findings were noted at necropsy.
- Interpretation of results:
- practically nontoxic
- Remarks:
- Migrated information
- Conclusions:
- The mean lethal dose of after single dermal administration to rats of both sexes, observed over a period of 14 days, was found to be greater than 2000 mg/kg body weight.
- Executive summary:
In a GLP-compliant dermal acute toxicity study according to OECD guideline 402, a group of five male and five female HanIbm:WIST (SPF) rats was treated with test material at 2000 mg/kg by dermal application. The test article was suspended in bi-distilled water and a drop of TWEEN 80 at a concentration of 0.5 g/ml and administered at a volume of 4 ml/kg. Four times during day 1 and once daily during days 2-15 the animals were examined for clinical signs. Mortality and viability were recorded together with clinical signs at the same time intervals. Body weights were recorded on day 1 before administration and on days 8 and 15. All animals were necropsied and examined macroscopically. No deaths occurred during the study period. Neither clinical signs of systemic toxicity nor local effects of the test article on the skin at the application site were observed during the observation period. The body weight of the rats was within the range of physiological variability known for rats of this strain and age. A slight loss of body weight was observed in one female animal during the first and second observation week and in two female animals during the second observation period. No macroscopic organ findings were observed at necropsy. In conclusion, the mean lethal dose of the test item after single dermal administration to rats of both sexes, observed over a period of 14 days, exceeded 2000 mg/kg body weight.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- discriminating dose
- Value:
- 2 000 mg/kg bw
Additional information
Oral Toxicity
In a GLP-compliant acute oral toxicity study according to OECD guideline 401, a group of five male and five female HanIbm:WIST (SPF) rats was treated with test material at 2000 mg/kg by oral gavage followed by an observation period of 15 days (RCC, 1996). The test article was suspended in bi-distilled water and a drop of TWEEN 80 at a concentration of 0.2 g/ml and administered at a volume of 10 ml/kg. No deaths occurred during the study. No clinical signs of toxicity were observed during the observation period. The body weight of the animals was within the range of physiological variability known for rats of this strain and age. No macroscopic findings were observed at necropsy. In conclusion, the mean lethal dose (LD50) of the test item after single oral administration to rats of both sexes was found to exceed 2000 mg/kg.
This result is supported by a second oral toxicity study in Wistar rats, which produced an oral LD50 of greater than 5000 mg/kg (limit dose) in both sexes (MB Research Labs, 1984).
Dermal toxicity
In a GLP-compliant dermal acute toxicity study according to OECD guideline 402, a group of five male and five female HanIbm:WIST (SPF) rats was treated with test material at 2000 mg/kg by dermal application. The test article was suspended in bi-distilled water and a drop of TWEEN 80 at a concentration of 0.5 g/ml and administered at a volume of 4 ml/kg. No deaths occurred during the study period. Neither clinical signs of systemic toxicity nor local effects of the test article on the skin at the application site were observed during the observation period. The body weight of the rats was within the range of physiological variability known for rats of this strain and age. A slight loss of body weight was observed in one female animal during the first and second observation week and in two female animals during the second observation period. No macroscopic organ findings were observed at necropsy. In conclusion, the mean lethal dose of the test item after single dermal administration to rats of both sexes, observed over a period of 14 days, exceeded 2000 mg/kg body weight.
This result is supported by a second dermal toxicity study in New Zealand White rabbits, which produced a dermal LD50 of greater than 2000 mg/kg (limit dose) in both sexes (MB Research Labs, 1984).
Justification for classification or non-classification
Classification, Labelling, and Packaging Regulation (EC) No. 1272/2008
The available experimental test data are reliable and suitable for classification purposes under Regulation 1272/2008. No mortality occurred at the limit dose of 2000 mg/kg bw. As a result the substance is not considered to be classified for acute oral or dermal toxicity under Regulation (EC) No. 1272/2008,as amended for the seventh time in Regulation (EC) No 2015/1221.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)